Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎 Read how
Close

Neurosense Therapeutics Ltd (NRSN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Neurosense Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.220 +0.070    +6.09%
11:43:41 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 61,530
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.194 - 1.290
Neurosense Therapeutics 1.220 +0.070 +6.09%

Neurosense Therapeutics Ltd Company Profile

 
Get an in-depth profile of Neurosense Therapeutics Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

14

Equity Type

ORD

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company’s lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer’s, as well as under preclinical studies for the treatment of Parkinson’s disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer’s disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.

Contact Information

Address Building B 11 HaMenofim Street
Herzliya, 4672562
Israel
Phone 972 9 799 6183
Fax -

Top Executives

Name Age Since Title
Jeremy M. Shefner - - Chair of Scientific Advisory Board
Jinsy Andrews - - Scientific Advisory Board Member
Orla Hardiman - - Scientific Advisory Board Member
Jeffery Rosenfeld - - Scientific Advisory Board Member
Merit Cudkowicz 58 - Scientific Advisory Board Member
Cary John Claiborne 62 2021 Independent External Director
Mark Wayne Leuchtenberger 55 2021 Independent Chairman of the Board
Caren Deardorf 57 2021 Independent Director
Revital Mandil-Levin 49 2022 Director
Christine A. Pellizzari 55 2021 Independent External Director
Alon Ben-Noon 45 2016 Co-Founder, CEO & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NRSN Comments

Write your thoughts about Neurosense Therapeutics Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Stelove
Stelove Dec 05, 2023 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy time
Rita Weber
Rita Weber Mar 23, 2022 3:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Another dip in
Robin Clerici
Erithacus Mar 22, 2022 1:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
-31% but recovering
Adrian Gabriel IS
Adrian Gabriel IS Mar 21, 2022 3:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Took an eye on $ARDX
Vitalik Khudeev
Vitalik Khudeev Mar 01, 2022 8:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i am in
Vitalik Khudeev
Vitalik Khudeev Mar 01, 2022 8:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i am in
Vitalik Khudeev
Vitalik Khudeev Mar 01, 2022 8:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i'm in 💙
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email